探讨支架植入联合支气管动脉栓塞化疗治疗肺癌致上腔静脉综合征（SVCS）的疗效。

选取2008年1月—2016年12月我院收治的9例上腔静脉综合征患者，均行支架植入联合支气管动脉栓塞化疗治疗。

9例患者共植入10枚自膨支架，均一次置放到位，其中1例由于狭窄范围较长，分别给予置放2枚自膨支架，9例以球囊（10～12 mm）行后扩张，所有患者支架植入术后血管造影显示血流通畅，病变段上腔静脉腔扩大。术中无上腔静脉破裂等严重并发症发生。支架植入后3～7 d内所有患者临床症状明显改善。9例患者中，1例失访，8例接受随访，随访期6～36个月。7例患者在生存期内保持支架通畅。1例患者支架植入46 d后SVCS复发，在原支架内重新植入1枚自膨支架后上腔静脉恢复通畅。

支架植入联合支气管动脉栓塞化疗是治疗肺癌致上腔静脉综合征的一种高效、微创、安全、并发症少的方法。

To evaluate the efficacy of stent implantation combined with bronchial arterial chemoembolization in the treatment of lung cancer related superior vena cava syndrome.

From January 2008 to December 2016, 9 patients with superior vena cava syndrome admitted to our hospital were treated with stent implantation and bronchial artery chemoembolization.

Among these patients, 10 self-expandable stents were positioned in place, with one patient who had a long stenosis, and thus having two self-expandable stents placed. 9 had balloon (10-12 mm). The stent implantation angiography showed a smooth flow, and the lesion segment SVC cavity expanded among these patients. No SVC rupture and other serious complications were observed. The clinical symptoms of all patients were improved 3~7 days after implantation. Of the 9 patients, one died and eight were followed up for 6 to 36 months. Seven patients remained unobstructed during their survival. 1 patient had SVCS recurrence 46 days after the implantation, however, a new self-expandable stent was placed in the original foci to restore patency.

Stent implantation combined with bronchial arterial chemoembolization is an effective method for the treatment of superior vena cava syndrome caused by lung cancer.